|Day's Range||7,973.38 - 8,052.40|
|52 Week Range||6,190.17 - 8,133.30|
U.S. stocks ended a choppy session slightly lower as investors considered stronger-than-expected economic data from China and a latest batch of corporate earnings results.
It’s a big week for the IPO market with 8 IPOs pricing this week alone. Yahoo Finance’s Alexis Christoforous speaks to Brian Sozzi about the insurance company Palomar Specialty, which will make its debut on the NASDAQ today.
Some of the forces that have propped up U.S. corporate profit margins face a major test as global trends shift, Bridgewater Associates said on Wednesday.
MARKET EXTRA Major U.S. exchanges will be closed on Good Friday, while the most-watched European markets will be closed on both Good Friday and Easter Monday. Good Friday is a Christian holiday that celebrates the crucifixion of Jesus Christ, while Easter Monday is the Monday following Easter Sunday, which celebrates Christ’s resurrection.
You don’t have to look hard for reasons why stocks are nearing new highs—and most of them can be found in the wreckage of the December selloff.
Global stocks fell Thursday after Wall Street declined despite encouraging Chinese economic data. Benchmarks in London, Frankfurt, Shanghai and Tokyo retreated. U.S. stocks fell despite data showing Chinese ...
Major Asia-Pacific markets closed lower. On the trade front, sources told CNBC on Wednesday that Beijing officials are looking at U.S. President Donald Trump's upcoming international travel dates that might offer potential for a summit off of American soil. Major Asia-Pacific markets closed lower on Thursday, with Indonesia's benchmark index bucking the overall trend as stocks jumped on election hopes.
JPMorgan Chase & Co.'s CFO Marianne Lake is scheduled to step down as the bank's top financial officer after about seven years in the role, effective May 1, the bank said in an internal memo Wednesday afternoon. She will become head of all of the company's consumer-lending operations. The 49-year-old executive will be replaced as CFO by Jennifer Piepszak, JPMorgan's current CEO of card services. Lake was appointed CFO and member of the bank's operating committee back in 2012, and has been viewed by industry watchers (and still is) as a possible successor to CEO Jamie Dimon, when he steps down. Dimon said of the planned change: "We're extremely fortunate that she will be heading a major group of businesses that is core to how we serve millions of Chase customers." Lake will remain a member of the bank's operating committee and become CEO of consumer lending, which will include the bank's credit card, home and auto loan businesses. Meanwhile, Piepszak, 49, is a more than 20-year veteran at JPMorgan Chase. Shares of JPMorgan, the nation's largest bank by market cap, finished Wednesday's session up 2.8% and have gained 17.1% so far this year, with that rise aided by better-than-expected results from the bank last week. JPMorgan's stock performance has thus far outperformed the broad-market S&P 500 index , which is up 15.7% year to date, and the Dow Jones Industrial Average, where it is a component, which has returned 13.4% over the same period. Corrections and amplifications: Fixes the ages of both Piepszak and Lake, which was incorrectly stated in an earlier version. Both executives are 49 years old.
A recent resurgence for stocks after a more than six-month corrective hiatus has many market participants questioning its durability, with trading volumes holding near the lowest levels of 2019.
U.S. stocks ended slightly lower on Wednesday as a drop in healthcare shares overshadowed a string of positive corporate earnings and upbeat economic data from the United States and China. All three major ...
Stocks around the globe fell on Wednesday as a continued flight from healthcare shares dragged on Wall Street, overshadowing upbeat economic data from China. The S&P 500 dipped as the healthcare index dived 2.9% to erase its year-to-date gains on continued fallout from concerns about potential changes to U.S. policy, including a "Medicare for All" proposal by Senator Bernie Sanders. The decline in U.S. stocks weighed on MSCI's 47-country world index, which was buoyed earlier by better-than-expected Chinese data showing the country's economy grew 6.4% in the first quarter.
U.S. stocks headed lower on Wednesday, as a selloff in healthcare stocks extended for a second day, overshadowing a rally in chipmakers led by Qualcomm. Medical device maker Abbott Laboratories Inc fell 3.8%, despite quarterly results beating estimates. UnitedHealth Group Inc, Pfizer Inc and Merck & Co fell more than 2% and were the biggest drags on the broader S&P 500 index.
Tuesday’s rally put all three indexes less than 1.5% from records, but investors were too skittish to push forward. The Dow Jones Industrial Average ended down 0.01% to 26,449.54. The S&P 500 lost 6.61 points, or 0.23%, to end at 2900.45, and the Nasdaq Composite slipped 4.15 points, or 0.05%, to close at 7996.08.
World stock markets gave up early gains as a continued flight from healthcare shares dragged on Wall Street, overshadowing upbeat economic data from China. The S&P 500 dipped as the healthcare index dived 3.4% to erase its year-to-date gains on continued fallout from concerns about potential changes to U.S. policy, including a "Medicare for All" proposal by Senator Bernie Sanders.
Stocks finished a wobbly day of trading on Wall Street Wednesday with modest losses that erased most of the market's slight gains from a day earlier. A sharp sell-off in health care companies far outweighed ...
U.S. stocks ended slightly lower on Wednesday as a drop in healthcare shares overshadowed a string of positive corporate earnings and upbeat economic data from the United States and China. All three major U.S. stock indexes ended the session in negative territory, with the S&P 500 remaining just within a percent below its record high reached in September. UnitedHealth Group Inc, Pfizer Inc, Merck & Co Inc and Abbott Laboratories all closed down between 1.9% and 4.7%, and were among the biggest drags on the broader S&P 500.
U.S. stocks close lower Wednesday as the health care sector slumped on concerns over potential adverse impact from future policy changes.
Herman Cain said Wednesday he had no plans to withdraw from consideration for a seat on the Federal Reserve Board, according to a report by the Wall Street Journal. While President Donald Trump has not sent Cain's nomination to Capitol Hill, several Senate Republicans have already said they would not support him. That means the former CEO of a pizza company, and candidate for the Republican presidential nomination in 2012, would need support from Democrats to be confirmed. Cain said the Fed needs "new voices."
Stocks ended slightly lower Wednesday, with a selloff in the health care sector offsetting corporate earnings as investors paid little heed to unexpectedly strong Chinese economic data. The S&P 500 ended with a loss of around 7 points, or 0.2%, near 2,900, according to preliminary figures, while the Dow Jones Industrial Average edged around 3 points lower to finish around 26,450. The Nasdaq Composite edged down around 4 points, or less than 0.1%, to end near 7,997. Health care was the worst-performing sector in the S&P 500, falling 2.9% and turning negative for 2019, down 0.9% year to date. The sector-tracking Health Care Select Sector SPDR ETF declined 2.7% Wednesday and is off 0.7% so far this year. Analysts have tied weakness in the sector in part to the political climate, including calls for lower drug prices and a "Medicare for All"-type health insurance overhaul.
U.S. stocks ended slightly lower on Wednesday as a drop in healthcare shares overshadowed a string of positive corporate earnings and upbeat economic data from the United States and China. Based on the ...
Plunging healthcare stocks dragged Wall Street lower on Wednesday, offsetting a spate of upbeat corporate earnings and encouraging economic data from the United States and China. All three major U.S. stock indexes were down, but the S&P 500 slipped to more than a percent below its record high reached in September.
Although Chinese economic data came in ahead of expectations, investors were weighing that news with a spate of earnings reports, now that first-quarter reporting season is in full swing.